{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:40:15Z","timestamp":1791286815607,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF17SA0031406"],"award-info":[{"award-number":["NNF17SA0031406"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF17SA0031406"],"award-info":[{"award-number":["NNF17SA0031406"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85508-y","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T02:05:59Z","timestamp":1743127559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Non-invasive liver fibrosis markers are increased in obese individuals with non-alcoholic fatty liver disease and the metabolic syndrome"],"prefix":"10.1038","volume":"15","author":[{"given":"Anders","family":"Askeland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke Wehner","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimoza","family":"Gjela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Br\u00f8ndum","family":"Fr\u00f8kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"H\u00f8jlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiken","family":"Mellergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aase","family":"Handberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"85508_CR1","unstructured":"Le, M.H. et al. 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol (2021)."},{"key":"85508_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.metabol.2018.09.005","volume":"92","author":"YC Chooi","year":"2019","unstructured":"Chooi, Y. C., Ding, C. & Magkos, F. The epidemiology of obesity. Metabolism 92, 6\u201310 (2019).","journal-title":"Metabolism"},{"key":"85508_CR3","doi-asserted-by":"crossref","unstructured":"Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19\u00b72 million participants. Lancet 387, 1377\u20131396 (2016).","DOI":"10.1016\/S0140-6736(16)30054-X"},{"key":"85508_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/hep.23280","volume":"51","author":"E Fabbrini","year":"2010","unstructured":"Fabbrini, E., Sullivan, S. & Klein, S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51, 679\u2013689 (2010).","journal-title":"Hepatology"},{"key":"85508_CR5","doi-asserted-by":"crossref","unstructured":"Alberti, K.G., Zimmet, P. & Shaw, J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23, 469\u2013480 (2006).","DOI":"10.1111\/j.1464-5491.2006.01858.x"},{"key":"85508_CR6","doi-asserted-by":"crossref","unstructured":"Cohen, J.C., Horton, J.D. & Hobbs, H.H. Human fatty liver disease: old questions and new insights. Science (New York, N.Y.) 332, 1519\u20131523 (2011).","DOI":"10.1126\/science.1204265"},{"key":"85508_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","volume":"19","author":"JV Lazarus","year":"2022","unstructured":"Lazarus, J. V. et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol 19, 60\u201378 (2022).","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"85508_CR8","unstructured":"Network, G.B.o.D.C. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Reference Life Table. 2021 [cited]"},{"key":"85508_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller, R. & Brenner, D. A. Liver fibrosis. J Clin Invest 115, 209\u2013218 (2005).","journal-title":"J Clin Invest"},{"key":"85508_CR10","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","volume":"128","author":"V Ratziu","year":"2005","unstructured":"Ratziu, V. et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128, 1898\u20131906 (2005).","journal-title":"Gastroenterology"},{"key":"85508_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","volume":"63","author":"EASL-ALEH Clinical Practice Guidelines","year":"2015","unstructured":"EASL-ALEH Clinical Practice Guidelines. Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 63, 237\u2013264 (2015).","journal-title":"J Hepatol"},{"key":"85508_CR12","doi-asserted-by":"crossref","unstructured":"Vallet-Pichard, A. et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 46, 32\u201336 (2007).","DOI":"10.1002\/hep.21669"},{"key":"85508_CR13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","volume":"48","author":"L Castera","year":"2008","unstructured":"Castera, L., Forns, X. & Alberti, A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 48, 835\u2013847 (2008).","journal-title":"J Hepatol"},{"key":"85508_CR14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00261-019-02382-9","volume":"45","author":"DH Hoffman","year":"2020","unstructured":"Hoffman, D. H. et al. T1 mapping, T2 mapping and MR elastography of the liver for detection and staging of liver fibrosis. Abdom Radiol (NY) 45, 692\u2013700 (2020).","journal-title":"Abdom Radiol (NY)"},{"key":"85508_CR15","doi-asserted-by":"crossref","unstructured":"Li, Z. et al. Assessment of liver fibrosis by variable flip angle T1 mapping at 3.0T. J Magn Reson Imaging 43, 698\u2013703 (2016).","DOI":"10.1002\/jmri.25030"},{"key":"85508_CR16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/jmri.23731","volume":"37","author":"SK Venkatesh","year":"2013","unstructured":"Venkatesh, S. K., Yin, M. & Ehman, R. L. Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging 37, 544\u2013555 (2013).","journal-title":"J Magn Reson Imaging"},{"key":"85508_CR17","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3748\/wjg.v12.i19.3044","volume":"12","author":"QH Nie","year":"2006","unstructured":"Nie, Q. H. et al. Correlation between TIMP-1 expression and liver fibrosis in two rat liver fibrosis models. World J Gastroenterol 12, 3044\u20133049 (2006).","journal-title":"World J Gastroenterol"},{"key":"85508_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0009-8981(94)90133-3","volume":"227","author":"J Collazos","year":"1994","unstructured":"Collazos, J. & D\u00edaz, F. Role of the measurement of serum procollagen type III N-terminal peptide in the evaluation of liver diseases. Clin Chim Acta 227, 37\u201343 (1994).","journal-title":"Clin Chim Acta"},{"key":"85508_CR19","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/hep.23050","volume":"50","author":"AE Feldstein","year":"2009","unstructured":"Feldstein, A. E. et al. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 50, 1072\u20131078 (2009).","journal-title":"Hepatology"},{"key":"85508_CR20","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","volume":"46","author":"S Hemmann","year":"2007","unstructured":"Hemmann, S., Graf, J., Roderfeld, M. & Roeb, E. Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 46, 955\u2013975 (2007).","journal-title":"J Hepatol"},{"key":"85508_CR21","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.cgh.2022.03.044","volume":"21","author":"F Tavaglione","year":"2023","unstructured":"Tavaglione, F. et al. Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol 21, 1523-1532.e1521 (2023).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"85508_CR22","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling, R. K. et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43, 1317\u20131325 (2006).","journal-title":"Hepatology"},{"key":"85508_CR23","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1053\/jhep.2002.36128","volume":"36","author":"X Forns","year":"2002","unstructured":"Forns, X. et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36, 986\u2013992 (2002).","journal-title":"Hepatology"},{"key":"85508_CR24","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/apt.14621","volume":"47","author":"J Boursier","year":"2018","unstructured":"Boursier, J. et al. Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH. Aliment Pharmacol Ther 47, 1387\u20131396 (2018).","journal-title":"Aliment Pharmacol Ther"},{"key":"85508_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11695-013-1044-6","volume":"24","author":"KA Simo","year":"2014","unstructured":"Simo, K. A. et al. Does a calculated \u201cNAFLD fibrosis score\u201d reliably negate the need for liver biopsy in patients undergoing bariatric surgery?. Obes Surg 24, 15\u201321 (2014).","journal-title":"Obes Surg"},{"key":"85508_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1590\/S0004-28032010000200010","volume":"47","author":"SK Pimentel","year":"2010","unstructured":"Pimentel, S. K. et al. Evaluation of the nonalcoholic fat liver disease fibrosis score for patients undergoing bariatric surgery. Arq Gastroenterol 47, 170\u2013173 (2010).","journal-title":"Arq Gastroenterol"},{"key":"85508_CR27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s11695-007-9295-8","volume":"18","author":"K Qureshi","year":"2008","unstructured":"Qureshi, K., Clements, R. H. & Abrams, G. A. The utility of the \u201cNAFLD fibrosis score\u201d in morbidly obese subjects with NAFLD. Obesity surgery 18, 264\u2013270 (2008).","journal-title":"Obesity surgery"},{"key":"85508_CR28","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1007\/s11695-020-04996-1","volume":"31","author":"SA Alqahtani","year":"2021","unstructured":"Alqahtani, S. A. et al. Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease. Obes Surg 31, 2002\u20132010 (2021).","journal-title":"Obes Surg"},{"key":"85508_CR29","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s11695-016-2284-z","volume":"27","author":"AT Nassif","year":"2017","unstructured":"Nassif, A. T. et al. Performance of the Bard Scoring System in Bariatric Surgery Patients with Nonalcoholic Fatty Liver Disease. Obes Surg 27, 394\u2013398 (2017).","journal-title":"Obes Surg"},{"key":"85508_CR30","doi-asserted-by":"publisher","first-page":"e2008","DOI":"10.1210\/clinem\/dgab933","volume":"107","author":"S Qadri","year":"2022","unstructured":"Qadri, S. et al. Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease. J Clin Endocrinol Metab 107, e2008\u2013e2020 (2022).","journal-title":"J Clin Endocrinol Metab"},{"key":"85508_CR31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","volume":"1","author":"N Stefan","year":"2013","unstructured":"Stefan, N., H\u00e4ring, H. U., Hu, F. B. & Schulze, M. B. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol 1, 152\u2013162 (2013).","journal-title":"Lancet Diabetes Endocrinol"},{"key":"85508_CR32","doi-asserted-by":"crossref","unstructured":"Bl\u00fcher, M. Metabolically Healthy Obesity. Endocr Rev 41 (2020).","DOI":"10.1210\/endrev\/bnaa004"},{"key":"85508_CR33","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1053\/jhep.2003.50161","volume":"37","author":"G Marchesini","year":"2003","unstructured":"Marchesini, G. et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37, 917\u2013923 (2003).","journal-title":"Hepatology"},{"key":"85508_CR34","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78, 1966\u20131986 (2023).","journal-title":"Hepatology"},{"key":"85508_CR35","doi-asserted-by":"publisher","first-page":"G697","DOI":"10.1152\/ajpgi.00426.2010","volume":"300","author":"DJ Chiang","year":"2011","unstructured":"Chiang, D. J., Pritchard, M. T. & Nagy, L. E. Obesity, diabetes mellitus, and liver fibrosis. Am J Physiol Gastrointest Liver Physiol 300, G697-702 (2011).","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"85508_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c912","volume":"340","author":"B Liu","year":"2010","unstructured":"Liu, B., Balkwill, A., Reeves, G. & Beral, V. Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study. Bmj 340, c912 (2010).","journal-title":"Bmj"},{"key":"85508_CR37","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/gutjnl-2011-300342","volume":"61","author":"VW Wong","year":"2012","unstructured":"Wong, V. W. et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 61, 409\u2013415 (2012).","journal-title":"Gut"},{"key":"85508_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2021.101754","volume":"45","author":"H Tutunchi","year":"2021","unstructured":"Tutunchi, H. et al. Metabolically healthy and unhealthy obesity and the progression of liver fibrosis: A cross-sectional study. Clin Res Hepatol Gastroenterol 45, 101754 (2021).","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"85508_CR39","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1111\/liv.14184","volume":"39","author":"Y Kim","year":"2019","unstructured":"Kim, Y. et al. Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non-alcoholic fatty liver disease. Liver Int 39, 1884\u20131894 (2019).","journal-title":"Liver Int"},{"key":"85508_CR40","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.cgh.2007.07.020","volume":"5","author":"JA Talwalkar","year":"2007","unstructured":"Talwalkar, J. A., Kurtz, D. M., Schoenleber, S. J., West, C. P. & Montori, V. M. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol 5, 1214\u20131220 (2007).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"85508_CR41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s40139-014-0061-z","volume":"2","author":"DL Motola","year":"2014","unstructured":"Motola, D. L., Caravan, P., Chung, R. T. & Fuchs, B. C. Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions. Curr Pathobiol Rep 2, 245\u2013256 (2014).","journal-title":"Curr Pathobiol Rep"},{"key":"85508_CR42","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1016\/j.cgh.2023.03.032","volume":"21","author":"CM Canivet","year":"2023","unstructured":"Canivet, C. M. et al. Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 Patients. Clin Gastroenterol Hepatol 21, 3097-3106.e3010 (2023).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"85508_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5152\/dir.2020.19654","volume":"27","author":"A Erden","year":"2021","unstructured":"Erden, A. et al. MRI quantification techniques in fatty liver: the diagnostic performance of hepatic T1, T2, and stiffness measurements in relation to the proton density fat fraction. Diagn Interv Radiol 27, 7\u201314 (2021).","journal-title":"Diagn Interv Radiol"},{"key":"85508_CR44","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/jmri.23585","volume":"35","author":"R Rustogi","year":"2012","unstructured":"Rustogi, R. et al. Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging 35, 1356\u20131364 (2012).","journal-title":"J Magn Reson Imaging"},{"key":"85508_CR45","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s00330-021-08225-w","volume":"32","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis. Eur Radiol 32, 950\u2013958 (2022).","journal-title":"Eur Radiol"},{"key":"85508_CR46","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cgh.2007.06.012","volume":"5","author":"M Yin","year":"2007","unstructured":"Yin, M. et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 5, 1207-1213.e1202 (2007).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"85508_CR47","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1007\/s00204-021-03121-0","volume":"95","author":"S Korver","year":"2021","unstructured":"Korver, S. et al. The application of cytokeratin-18 as a biomarker for drug-induced liver injury. Arch Toxicol 95, 3435\u20133448 (2021).","journal-title":"Arch Toxicol"},{"key":"85508_CR48","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/S0168-8278(97)80454-0","volume":"26","author":"Y Murawaki","year":"1997","unstructured":"Murawaki, Y., Ikuta, Y., Idobe, Y., Kitamura, Y. & Kawasaki, H. Tissue inhibitor of metalloproteinase-1 in the liver of patients with chronic liver disease. J Hepatol 26, 1213\u20131219 (1997).","journal-title":"J Hepatol"},{"key":"85508_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.yexcr.2004.02.019","volume":"297","author":"B Schutte","year":"2004","unstructured":"Schutte, B. et al. Keratin 8\/18 breakdown and reorganization during apoptosis. Exp Cell Res 297, 11\u201326 (2004).","journal-title":"Exp Cell Res"},{"key":"85508_CR50","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","volume":"6","author":"V Hernandez-Gea","year":"2011","unstructured":"Hernandez-Gea, V. & Friedman, S. L. Pathogenesis of liver fibrosis. Annu Rev Pathol 6, 425\u2013456 (2011).","journal-title":"Annu Rev Pathol"},{"key":"85508_CR51","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1053\/j.gastro.2019.09.008","volume":"158","author":"H Hagstr\u00f6m","year":"2020","unstructured":"Hagstr\u00f6m, H., Talb\u00e4ck, M., Andreasson, A., Walldius, G. & Hammar, N. Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease. Gastroenterology 158, 200\u2013214 (2020).","journal-title":"Gastroenterology"},{"key":"85508_CR52","volume":"13","author":"T Bukhari","year":"2021","unstructured":"Bukhari, T. et al. Diagnostic Accuracy of the Forns Score for Liver Cirrhosis in Patients With Chronic Viral Hepatitis. Cureus 13, e14477 (2021).","journal-title":"Cureus"},{"key":"85508_CR53","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1210\/jc.2005-0482","volume":"90","author":"AD Karelis","year":"2005","unstructured":"Karelis, A. D. et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 90, 4145\u20134150 (2005).","journal-title":"J Clin Endocrinol Metab"},{"key":"85508_CR54","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.diabet.2017.02.007","volume":"43","author":"Y Guti\u00e9rrez-Grobe","year":"2017","unstructured":"Guti\u00e9rrez-Grobe, Y. et al. Less liver fibrosis in metabolically healthy compared with metabolically unhealthy obese patients with non-alcoholic fatty liver disease. Diabetes Metab 43, 332\u2013337 (2017).","journal-title":"Diabetes Metab"},{"key":"85508_CR55","unstructured":"World Health Organization. Waist circumference and waist-hip ratio: Report of a WHO expert consultation, Geneva, 8\u201311 December 2008. (2011) https:\/\/apps.who.int\/iris\/handle\/10665\/44583 [Accessed May 30, 2022]"},{"key":"85508_CR56","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499\u2013502 (1972).","journal-title":"Clin Chem"},{"key":"85508_CR57","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.2337\/diacare.21.12.2191","volume":"21","author":"JC Levy","year":"1998","unstructured":"Levy, J. C., Matthews, D. R. & Hermans, M. P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21, 2191\u20132192 (1998).","journal-title":"Diabetes Care"},{"key":"85508_CR58","unstructured":"Hines, G., Kennedy, I., Holman R. HOMA2 Calculator. https:\/\/www.dtu.ox.ac.uk\/homacalculator\/ [Accessed October 21, 2022]"},{"key":"85508_CR59","unstructured":"Boursier, J,. MACK3 Calculator. http:\/\/forge.info.univ-angers.fr\/~gh\/wstat\/mack3-calculator.php [Accessed September 1, 2024]"},{"key":"85508_CR60","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.1007\/s00261-021-03276-5","volume":"46","author":"E Steinkohl","year":"2021","unstructured":"Steinkohl, E., Olesen, S. S., Hansen, T. M., Drewes, A. M. & Fr\u00f8kj\u00e6r, J. B. T1 relaxation times and MR elastography-derived stiffness: new potential imaging biomarkers for the assessment of chronic pancreatitis. Abdom Radiol (NY) 46, 5598\u20135608 (2021).","journal-title":"Abdom Radiol (NY)"},{"key":"85508_CR61","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2214\/AJR.17.17812","volume":"209","author":"CA Campo","year":"2017","unstructured":"Campo, C. A. et al. Standardized Approach for ROI-Based Measurements of Proton Density Fat Fraction and R2* in the Liver. AJR Am J Roentgenol 209, 592\u2013603 (2017).","journal-title":"AJR Am J Roentgenol"},{"key":"85508_CR62","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/jmri.25843","volume":"47","author":"CW Hong","year":"2018","unstructured":"Hong, C. W. et al. Optimization of region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification. J Magn Reson Imaging 47, 988\u2013994 (2018).","journal-title":"J Magn Reson Imaging"},{"key":"85508_CR63","unstructured":"J., C. Statistical Power Analysis for the Behavioral Sciences., 2nd ed. edn. New York: Routledge, 1988."},{"key":"85508_CR64","unstructured":"Team., R.C. R: A language and environment for statistical computing. [manual]. Vienna, Austria: R Foundation for Statistical Computing. (2022)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85508-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85508-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85508-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:42:36Z","timestamp":1743381756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85508-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85508"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85508-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10652"}}